PML is a ROS sensor activating p53 upon oxidative stress
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Promyelocytic leukemia (PML) nuclear bodies (NBs) recruit partner proteins, including p53 and its regulators, thereby controlling their abundance or function. Investigating arsenic sensitivity of acute promyelocytic leukemia, we proposed that PML oxidation promotes NB biogenesis. However, physiological links between PML and oxidative stress response in vivo remain unexplored. Here, we identify PML as a reactive oxygen species (ROS) sensor. Pml−/− cells accumulate ROS, whereas PML expression decreases ROS levels. Unexpectedly, Pml−/− embryos survive acute glutathione depletion. Moreover, Pml−/− animals are resistant to acetaminophen hepatotoxicity or fasting-induced steatosis. Molecularly, Pml−/− animals fail to properly activate oxidative stress–responsive p53 targets, whereas the NRF2 response is amplified and accelerated. Finally, in an oxidative stress–prone background, Pml−/− animals display a longevity phenotype, likely reflecting decreased basal p53 activation. Thus, similar to p53, PML exerts basal antioxidant properties but also drives oxidative stress–induced changes in cell survival/proliferation or metabolism in vivo. Through NB biogenesis, PML therefore couples ROS sensing to p53 responses, shedding a new light on the role of PML in senescence or stem cell biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. PML is required for the fasting-activated p53 response. (a) Livers from fed or 18-h–fasted Pml−/− and Pml+/+ mice (top), hematoxylin, phloxine, and saffron staining (middle; bar, 10 µm), and oil red O staining (bottom; bar, 10 µm). Quantification of oil red staining from n = 5 mice. Error bars represent SEM. *, P < 0.05; ****, P < 0.0001 (t test). (b) Image (left; bar, 10 µm) and quantification (middle; ****, P < 0.0001 [t test]; error bars represent SEM) of oil red O staining and quantitative PCR analysis of the indicated p53 targets (right; error bars represent SEM) from fasted or fed mice treated or not with pifithrin-α. (c) Hematoxylin, phloxine, and saffron staining (left; bar, 10 µm) and quantitative PCR analysis of indicated p53 targets (right) from fasted mice treated or not with N-acetylcysteine (NAC). Error bars represent SEM. **, P < 0.01. (d) Western blot analysis of p53 and GAPDH from livers of indicated mice. Representative experiment with two mice per condition (fed and 6-h fasted) from n = 2 replicates. (e) Immunofluorescent PML staining (green) upon fasting in liver cryosections (blue, DAPI). Bar, 5 µm. (f) Box and whisker plot (Tukey) representing γH2AX foci on liver sections of Pml−/− and Pml+/+ littermates. Dots were counted from 100 nuclei of four fed mice or two mice fasted for 6 h or 18 h. **, P < 0.01 (Mann–Whitney test). (g) mRNA levels (transcriptomes) from the p53 (top) and NRF2 (bottom) signature in Pml−/− livers relative to their control littermate from fed or fasted mice. (h) Survival of Pml−/− and Pml+/+ littermates. **, P < 0.01 (Gehan–Breslow–Wilcoxon test). (i) Graphs representing quantitative PCR measurement of indicated p53 and NRF2 targets. Mean values with SEM from the indicated number of mice (in parentheses) are shown. **, P < 0.01.](https://figures.cochat.ai/paper-figures/98e48a72ef704f44adc2453c61044f9e/pml-is-a-ros-sensor-activating-p53-upon-oxidative-stress-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, PML bodies act as sensors of ROS and oxidative damage (Niwa-Kawakita et al., 2017) and can also be non-exclusive biomarkers of cellular senescence (Vernier et al., 2011).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Niwa-Kawakita et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atmospheric carbon dioxide concentrations over the past 60 million years
Pearson, P. N., & Palmer, M. R. (2000) · Nature · doi:10.1038/35021000 · Cited by 1,771
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121 · cited 1×
“Importantly, p53 antioxidant functions were directly linked to its antitumor effects (Sablina et al., 2005).”
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 879 · cited 1×
“PML may be solely an indirect global enhancer of p53 responses initiated by other stress-induced pathways, such as DNA damage (Bernardi and Pandolfi, 2007; Brady et al., 2011).”
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734 · cited 1×
“PML was also proposed to favor NRF2 degradation (Malloy et al., 2013), but loss of this PML negative-feedback mechanism should yield low basal ROS levels.”
Self-citationLallemand-Breitenbach, V., & de The, H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000661 · Cited by 563
Self-citationThe deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548 · cited 1×
“Defective ROS homeostasis in Pml−/− animals may explain the multiplicity of PML-sensitive biological pathways, including PTEN/AKT or HIF1A (Bernardi et al., 2006; Trotman et al., 2006; Song et al., 2008).”
BackgroundDistinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533 · cited 1×
“PML may be solely an indirect global enhancer of p53 responses initiated by other stress-induced pathways, such as DNA damage (Bernardi and Pandolfi, 2007; Brady et al., 2011).”
Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1361 · Cited by 488
Self-citation
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Gentric, G., Kieffer, Y., Mieulet, V., Goundiam, O., Bonneau, C., Nemati, F., Hurbain, I., Raposo, G., Popova, T., Stern, M.-H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.002 · Cited by 310
“However, when detected in tumors, PML acts as a potent proapoptotic factor through activation of TP53 or Rb/E2F pathway (Vernier et al., 2011; Ablain et al., 2014; Niwa-Kawakita et al., 2017).”
BackgroundSelf-citationAcute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
de Thé, H., Pandolfi, P. P., & Chen, Z. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.002 · Cited by 297
The complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 261
PML nuclear bodies: from architecture to function
Lallemand-Breitenbach, V., & de Thé, H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.03.011 · Cited by 244
Self-citationSumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts
Celen, A. B., & Sahin, U. (2020) · The FEBS Journal · doi:10.1111/febs.15319 · Cited by 245
PML nuclear bodies and chromatin dynamics: catch me if you can!
Corpet, A., Kleijwegt, C., Roubille, S., Juillard, F., Jacquet, K., Texier, P., & Lomonte, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa828 · Cited by 203
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
Xu, H., Zhao, H., Ding, C., Jiang, D., Zhao, Z., Li, Y., Ding, X., Gao, J., Zhou, H., Luo, C., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01231-4 · Cited by 183
“The p53 signaling pathway is vital in the response to ROS elevation and DNA damage, which further regulates cell cycle arrest and apoptosis.(37,38) Based on the RNA sequencing data, we identified 21 and 14 DEGs from the p53 signaling pathway in SW620 and HCT116 cells, respectively (Supplementary Fig.”
BackgroundThe Role of Oxidative Stress in Tumorigenesis and Progression
Li, K., Deng, Z., Lei, C., Ding, X., Li, J., & Wang, C. (2024) · Cells · doi:10.3390/cells13050441 · Cited by 153
Sumoylation in Physiology, Pathology and Therapy
Şahin, U., de Thé, H., & Lallemand-Breitenbach, V. (2022) · Cells · doi:10.3390/cells11050814 · Cited by 103
“Consistently, in mouse embryos, PML absence can promote survival at a time of exposure to the glutathione-synthesis inhibitor BSO, which normally induces loss-of-viability via apoptosis [64].”
BackgroundSelf-citationBaiyun, R., Li, S., Liu, B., Lu, J., Lv, Y., Xu, J., Wu, J., Li, J., Lv, Z., & Zhang, Z. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.06.046 · Cited by 98
RING tetramerization is required for nuclear body biogenesis and PML sumoylation
Wang, P., Benhenda, S., Wu, H., Lallemand-Breitenbach, V., Zhen, T., Jollivet, F., Peres, L., Li, Y., Chen, S.-J., Chen, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03498-0 · Cited by 85
Self-citationEffects of oxidative stress on viral infections: an overview
Kayesh, M. E. H., Kohara, M., & Tsukiyama–Kohara, K. (2025) · npj Viruses · doi:10.1038/s44298-025-00110-3 · Cited by 101
Liu, T., Ma, X., Ouyang, T., Chen, H., Lin, J., Liu, J., Xiao, Y., Yu, J., & Huang, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.174 · Cited by 91
Alolga, R. N., Wang, F., Zhang, X., Li, J., Tran, L. P., & Yin, X. (2022) · Antioxidants · doi:10.3390/antiox11071281 · Cited by 101
“Cellular and subcellular damage caused by oxidative stress has been identified as a cardinal pathological event in the etiologies of various diseases, including, but not limited to, inflammatory diseases [4], cardiovascular diseases [5], cancer [1,6], and the aging process [7].”
BackgroundActinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy
Wu, H.-C., Rérolle, D., Berthier, C., Hleihel, R., Sakamoto, T., Quentin, S., Benhenda, S., Morganti, C., Wu, C., Conte, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0177 · Cited by 85
Self-citationLi, Y., Liu, Y., Yu, X., Xu, Y., Pan, X., Sun, Y. E., Wang, Y., Song, Y.-H., & Shen, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02013-w · Cited by 95
To TRIM or not to TRIM: the balance of host–virus interactions mediated by the ubiquitin system
Hage, A., & Rajsbaum, R. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001341 · Cited by 82
“This effect was found not to originate from TRIM28’s known roles in the DNA damage response nor from ROS production during IAV infection, but rather from the ability of HPAIV strains to trigger the PKR/p38/MSK1 phosphorylation cascade, ultimately leading to phosphorylation of TRIM28 and an environment more permissive…”
BackgroundInfluentialFunctional Role of p53 in the Regulation of Chemical-Induced Oxidative Stress
Liu, X., Fan, L., Lu, C., Yin, S., & Hu, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6039769 · Cited by 80
Oxidative stress in leukemia and antioxidant treatment
Dong, C., Zhang, N., & Zhang, L. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001628 · Cited by 64
“Oxidative Stress-Related Transcription Factors in Leukemia Oxidative stress can activate various kinds of transcription factors, including NF-kB, Nuclear respiratory factor 1 (Nrf1), Nuclear factor erythroid 2-related factor 2 (Nrf2), Nuclear factor erythroid 2-related factor 2 (Nrf3), activating protein-1 (AP-1), p53…”
BackgroundTherapeutic strategy of arsenic trioxide in the fight against cancers and other diseases
Wang, Q. Q., Jiang, Y. H., & Naranmandura, H. (2020) · Metallomics · doi:10.1039/c9mt00308h · Cited by 61
Targeting PML in triple negative breast cancer elicits growth suppression and senescence
Arreal, L., Piva, M., Fernández, S., Revandkar, A., Schaub-Clerigué, A., Villanueva, J., Zabala‐Letona, A., Pujana-Vaquerizo, M., Astobiza, I., Cortázar, A. R., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0407-5 · Cited by 61
Alterations of redox and iron metabolism accompany the development of HIV latency
Shytaj, I. L., Lucic, B., Forcato, M., Penzo, C., Billingsley, J. M., Laketa, V., Bosinger, S. E., Stanić, M., Gregoretti, F., Antonelli, L., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102209 · Cited by 55
“ATO can induce oxidative stress, and it has been recently proposed that the oxidation process per se can modulate the biogenesis and turnover of PML NBs through post-translational modifications (Sahin et al , 2014a,b; Niwa-Kawakita et al , 2017).”
InfluentialThe Multiple Facets of ATRX Protein
Valenzuela, M., Amato, R., Sgura, A., Antoccia, A., & Berardinelli, F. (2021) · Cancers · doi:10.3390/cancers13092211 · Cited by 54
Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis
Khan, N., & Geiger, J. D. (2021) · Viruses · doi:10.3390/v13081466 · Cited by 58
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
Lehmann‐Che, J., Bally, C., Letouzé, É., Berthier, C., Yuan, H., Jollivet, F., Adès, L., Cassinat, B., Hirsch, P., Pigneux, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04384-5 · Cited by 51
Mayor, E. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1161814 · Cited by 52
“Promyelocytic leukemia (PML) is a sensor of ROS; when ROS is sensed, it activates p53 (Niwa-Kawakita et al., 2017).”
BackgroundKurihara, M., Kato, K., Sanbo, C., Shigenobu, S., Ohkawa, Y., Fuchigami, T., & Miyanari, Y. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.004 · Cited by 49
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
Dagher, T., Maslah, N., Edmond, V., Cassinat, B., Vainchenker, W., Giraudier, S., Pasquier, F., Verger, E., Niwa‐Kawakita, M., Lallemand-Breitenbach, V., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201268 · Cited by 49
Self-citationBercier, P., Wang, Q. Q., Zang, N., Zhang, J., Yang, C., Maimaitiyiming, Y., Abou-Ghali, M., Berthier, C., Wu, C., Niwa-Kawakita, M., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0453 · Cited by 45
“Thus, in physiologic conditions, the oxidation status of the sulfur atoms of C213 trio could be the rheostat of NB bio-genesis, accounting for their oxidative stress sensitivity (46, 48, 51).”
BackgroundInfluentialSelf-citationAssociation of p53 with Neurodegeneration in Parkinson’s Disease
Luo, Q., Sun, W., Wang, Y., Li, J., & Li, D.-W. (2022) · Parkinson s Disease · doi:10.1155/2022/6600944 · Cited by 49
“Cellular redox homeostasis is tightly regulated by p53 through transcription and modification of pro-oxidant and antioxidant protein [54, 55].”
Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy
Chen, D., Feng, C., Tian, X., Zheng, N., & Wu, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01268 · Cited by 40
Retinoic acid signaling in development and differentiation commitment and its regulatory topology
Wu, D., Khan, F. A., Zhang, K., Pandupuspitasari, N. S., Negara, W., Guan, K., Sun, F., & Huang, C. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110773 · Cited by 43
TDP-43 in nuclear condensates: where, how, and why
Lang, R., Hodgson, R. E., & Shelkovnikova, T. A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231447 · Cited by 40
Cenni, V., Kojić, S., Capanni, C., Faulkner, G., & Lattanzi, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7318796 · Cited by 34
“This has been demonstrated for p53, which is activated in PML-NBs of C2C12 myoblasts, upon exposure to ROS [105].”
BackgroundTRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
Wang, L., & Ning, S. (2021) · Viruses · doi:10.3390/v13020279 · Cited by 37
“Thus, TRIM19 plays a role in ROS‐mediated p53 responses, including senescence, cell survival/proliferation, and metabolism [95].”
Ji, X., Li, X., Wu, S., Hou, M., & Zhao, Y. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126566 · Cited by 33
Shao, X., Chen, Y., Xu, A., Xiang, D., Wang, W., Du, W., Huang, Y., Zhang, X., Cai, M., Xia, Z., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00955-8 · Cited by 34
Tessier, S., Ferhi, O., Geoffroy, M., González‐Prieto, R., Canat, A., Quentin, S., Pla, M., Niwa‐Kawakita, M., Bercier, P., Rérolle, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33147-6 · Cited by 33
Self-citationPhase separation is required for PML nuclear body biogenesis and function
Wu, W., Tan, Y., Yin, H., Jiang, M., Jiang, Y., Ma, X., Tong, Y., Li, Y., Zhang, H., Cai, X., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300216r · Cited by 31
Lång, A., Lång, E., & Bøe, S. O. (2019) · Cells · doi:10.3390/cells8080893 · Cited by 30
PML Nuclear bodies: the cancer connection and beyond
Abou-Ghali, M., & Lallemand-Breitenbach, V. (2024) · Nucleus · doi:10.1080/19491034.2024.2321265 · Cited by 30
“The assembly of PML bodies occurs in several steps: PML self-assembly through noncovalent interactions of RBCC domains [14,20,21] drives the formation of the spherical PML polymeric shell.”
BackgroundSelf-citationDu, C., Chen, X., Su, Q., Lu, W., Wang, Q., Yuan, H., Zhang, Z., Wang, X., Wu, H., & Qi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910618 · Cited by 28
Liu, J., Cao, L., Wang, Y., Zou, Y. F., Guo, Q., Chen, S., Jiang, B., Wu, X., Zheng, L., Zhang, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114366 · Cited by 31
Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates
Liebl, M., & Hofmann, T. (2022) · Cancers · doi:10.3390/cancers14194549 · Cited by 23
“Upon oxidative stress, PML NBs are crucial for p53 activation and the transactivation of anti-oxidant target genes [132].”
BackgroundOld dog, new trick: Trivalent arsenic as an immunomodulatory drug
Ye, Y., Gaugler, B., Mohty, M., & Malard, F. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15011 · Cited by 24
“On the other hand, As2O3 targets the wild-type PML proteins, leading to re-formation of PML NBs, subsequent p53 activation, and ultimately APL clearance (Ablain et al., 2014; Niwa-Kawakita et al., 2017).”
BackgroundLiu, Y., Wang, X., Wang, J., Wang, J., Duan, C., & Wang, J. (2022) · Viruses · doi:10.3390/v14020402 · Cited by 25
“ROS is a by-product of metabolism and plays an important role in cell signal transduction and homeostasis [33].”
BackgroundMaimaitiyiming, Y., Zhu, H., Yang, C., & Naranmandura, H. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1791173 · Cited by 23
Ineffective erythropoiesis in sickle cell disease: new insights and future implications
Nemer, W. E., Godard, A., & Hoss, S. E. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000642 · Cited by 22
“Future studies should focus on investigating the potential role of oxidative stress in apoptosis and cell senescence of SCD erythroblasts, as ROS production may alter the cell cycle by activating a promyelocytic leukemia/p53 signaling cascade [22].”
BackgroundPML nuclear bodies, membrane-less domains acting as ROS sensors?
Niwa‐Kawakita, M., Wu, H.-C., de Thé, H., & Lallemand-Breitenbach, V. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.007 · Cited by 21
Self-citationMetabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
Balasundaram, N., Ganesan, S., Chendamarai, E., Palani, H. K., Venkatraman, A., Alex, A. A., David, S., Kumar, S. P., Radhakrishnan, N. R., Yasar, M., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005300 · Cited by 21
PML-controlled responses in severe congenital neutropenia withELANE-misfolding mutations
Olofsen, P. A., Bosch, D. A., Roovers, O., van Strien, P. M. H., de Looper, H. W. J., Hoogenboezem, R. M., Barnhoorn, S., Mastroberardino, P. G., Ghazvini, M., van der Velden, V. H. J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003214 · Cited by 20
“Elevated PML-NB formation is a characteristic of cells undergoing acute and more excessive oxidative stress than cells under more physiological conditions.(19) The focus of this study was to unravel the function of PML in these cases.”
BackgroundInfluentialThe roles of KLHL family members in human cancers.
Ye, G., Wang, J., Yang, W., Li, J., Meng, Y., & Jin, X. (2022) · PubMed · Cited by 21
A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia
Hleihel, R., Hajj, H. E., Wu, H.-C., Berthier, C., Zhu, H., Massoud, R., Chakhachiro, Z. I., El-Sabban, M. E., de Thé, H., & Bazarbachi, A. A. (2021) · Haematologica · doi:10.3324/haematol.2020.274878 · Cited by 18
The PML hub: An emerging actor of leukemia therapies
Rérolle, D., & de Thé, H. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221213 · Cited by 19
“P53 targets and the antioxidant response (NRF2 targets) are activated following acute oxidative stress in a PML-dependentmanner (Guo et al., 2014b;Malloy et al., 2013; Niwa-Kawakita et al., 2017).”
BackgroundKnockdown of endogenous RNF4 exacerbates ischaemia‐induced cardiomyocyte apoptosis in mice
Qiu, F., Han, Y., Shao, X., Paulo, P., Li, W., Zhu, M., Tang, N., Guo, S., Chen, Y., Wu, H., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15363 · Cited by 17
Gong, L., Liao, L., Dai, X., Xue, X., Peng, C. Y., & Li, Y. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.08.009 · Cited by 17
Lee, C., Xin, G., Li, F., Wan, C., Yu, X., Feng, L., Wen, A., Cao, Y., & Huang, W. Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411554 · Cited by 19
NINJ1: A new player in multiple sclerosis pathogenesis and potential therapeutic target
Xu, Y., Zhang, E., Wei, L., Dai, Z., Chen, S., Zhou, S., & Huang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113021 · Cited by 17
Yang, J.-Y., Luo, C.-H., Wang, K., Tu, X.-Y., Xiao, Y., Ou, Y.-T., Xie, Y., Guan, C., & Zhong, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143165 · Cited by 16
Targeting innate immune responses to attenuate acetaminophen-induced hepatotoxicity
Wang, J., Zhang, L., Shi, Q. W., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115142 · Cited by 14
Smirnov, E. Y., Silonov, S. A., Shmidt, E. A., Nozdracheva, A., Pleskach, N., Kuranova, M. L., Gavrilova, A. A., Romanovich, A. E., Kuznetsova, I. М., Константинович, Т. К., et al. (2024) · Cells · doi:10.3390/cells13242075 · Cited by 12
Bassot, A., Chen, J., & Simmen, T. (2021) · Contact · doi:10.1177/25152564211001213 · Cited by 14
“While its MERC activity increases IP3Rmediated Ca2þ flux towards mitochondria, in its absence ROS increase (Niwa-Kawakita et al., 2017).”
BackgroundCryo-EM structure of PML RBCC dimer reveals CC-mediated octopus-like nuclear body assembly mechanism
Tan, Y., Li, J., Zhang, S., Zhang, Y., Zhuo, Z., Ma, X., Yin, Y., Jiang, Y., Cong, Y., & Meng, G. (2024) · Cell Discovery · doi:10.1038/s41421-024-00735-3 · Cited by 11
“Although fusion of a green fl uorescent protein (GFP) at the PML N-terminus (GFP-PML) has frequently been used in the investigation of PML NB formation 60,61,74 , we also performed a control experiment of GFP alone (Supplementary Fig.”
Interplay between RNA Viruses and Promyelocytic Leukemia Nuclear Bodies
Neerukonda, S. N. (2021) · Veterinary Sciences · doi:10.3390/vetsci8040057 · Cited by 13
PML-Nuclear Bodies Regulate the Stability of the Fusion Protein Dendra2-Nrf2 in the Nucleus
Burroughs, A. F., Eluhu, S., Whalen, D. S., Goodwin, J. S., Sakwe, A. M., & Arinze, I. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490033 · Cited by 11
PML Body Component Sp100A Is a Cytosolic Responder to IFN and Activator of Antiviral ISGs
Dong, H., Wu, W., Li, J., Ma, Y., Deng, X., Guo, D., & Xu, P. (2022) · mBio · doi:10.1128/mbio.02044-22 · Cited by 10
Biomaterials strategy for promoting palatal wound healing
Tong, W., Ren, J., Yao, X., Wang, S., Li, W., Zheng, L., Hong, X., & Zhao, S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1646629 · Cited by 9
Roles of host SUMOylation in bacterial pathogenesis
Ma, X., Zhao, C., Xu, Y., & Zhang, H. (2023) · Infection and Immunity · doi:10.1128/iai.00283-23 · Cited by 9
Huang, D., Zhao, D., Li, M., Chang, S.-Y., Xue, Y.-D., Xu, N., Li, S., Tang, N.-N., Gong, L.-L., Liu, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.76214 · Cited by 10
Das, U. B., Chawla‐Sarkar, M., Gangopadhyay, S. R., Dey, S., & Sharma, R. D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295522 · Cited by 9
Nuclear Organization in Response to Stress: A Special Focus on Nucleoli
Batnasan, E., Koivukoski, S., Kärkkäinen, M., & Latonen, L. (2022) · Results and problems in cell differentiation · doi:10.1007/978-3-031-06573-6_17 · Cited by 9
Bercier, P., & de Thé, H. (2024) · Cancers · doi:10.3390/cancers16071351 · Cited by 9
“…and oxidative stress induced by multiple drugs, like paracetamol, induces NB assembly in vivo, similar to ATO [113,189,190]. is a cysteine-rich, oxidation-prone protein, and oxidative stress induced by multiple drugs, like paracetamol, induces NB assembly in vivo, similar to ATO [113,189,190].”
BackgroundPromyelocytic leukemia protein targets MK2 to promote cytotoxicity
Chen, I., Chen, H., Lo, Y., Lai, P., Hsieh, F., Wu, Y., Shih, H., & Lai, M. (2021) · EMBO Reports · doi:10.15252/embr.202052254 · Cited by 8
“…is a tumor suppressor that regulates cell growth, cell cycle control, transcription, apoptosis, stress responses, epigenetic control, antiviral reactivity, senescence, telomere elongation, and stem cell renewal (Salomoni & Pandolfi, 2002; Bernardi & Pandolfi, 2007; Niwa-Kawakita et al , 2017).”
Cellular Senescence in the Regenerative Niche Hampers Skeletal Muscle Repair
Qiu, M., Li, Y., Wang, Q., Jian, X., Huang, J.-W., Gui, W., Hu, J., & Liao, H. (2025) · Aging and Disease · doi:10.14336/ad.2024.1501 · Cited by 10
“Similarly, PML bodies, acting as sensors for ROS and oxidative damage, can function as non-exclusive biomarkers of cellular senescence [38, 39].”
Qu, M., He, Q., Bao, H., Ji, X., Shen, T., Barkat, M. Q., Wu, X., & Zeng, L. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.02.011 · Cited by 6
Conformational exchange at a C2H2 zinc-binding site facilitates redox sensing by the PML protein
Bregnard, T. A., Fairchild, D., Erlandsen, H., Semenova, I. V., Szczepaniak, R., Ahmed, A., Weller, S. K., Korzhnev, D. M., & Bezsonova, I. (2023) · Structure · doi:10.1016/j.str.2023.06.014 · Cited by 6
Intracellular aggregations of biological elements: From simple to complex
Li, F., Lan, X., & Liang, X. (2021) · Aggregate · doi:10.1002/agt2.27 · Cited by 6
Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes
Udagawa, O., Kato-Udagawa, A., & Hirano, S. (2022) · Biology Open · doi:10.1242/bio.059130 · Cited by 5
Radwan, Z., Kassir, R., Feghali, F. A., Zaiter, R., Daher, M. A., Roufayel, R., Fajloun, Z., Mawlawi, H., El-Sabban, M. E., & Dassouki, Z. (2025) · Biomolecules · doi:10.3390/biom15101361 · Cited by 4
“Promyelocytic leukemia protein (PML) has been identified as a sensor of ROS, responding to oxidative stress by activating p53 and promoting Nrf2-dependent antioxidant responses [40,41].”
Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells
Hu, J., Zhang, B., Chen, J., Huang, G., Zhao, M., Zhou, H., Yang, F., Liu, K., Zheng, S., Tan, H., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1175 · Cited by 5
Antitumor activity of niclosamide-mediated oxidative stress against acute lymphoblastic leukemia
Yang, J., Liu, Y., Du, Z., Zhou, Q., Yang, L., Ye, Q., Pan, J., Zou, W., Chen, C., & Jin, B. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae035 · Cited by 4
Immunotoxicity of aristolochic acid I on early zebrafish (Danio rerio) embryos
Zhang, H., Cheng, B., Yu, H., Jia, K., Xia, X., Wang, X., Luo, Q., & Lu, H. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110305 · Cited by 4
Li, Y., Han, S., Niu, W., Gao, C., Wang, Y., Qin, M., Han, J., Xia, X., & Wang, H. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00143-25 · Cited by 5
“Niwa-Kawakita et al. (26) found that in animals, as ROS levels increased, the expression of p53 was upregulated, and identified the ROS sensor PML as a regulator of the p53 pathway (26).”
Udagawa, O., & Hirano, S. (2022) · Frontiers in Environmental Chemistry · doi:10.3389/fenvc.2022.797966 · Cited by 3
“Also, PML (promyelocytic leukemia-nuclear bodies (PML-NBs) resident) knockout mice develop normally (Niwa-Kawakita et al., 2017).”
BackgroundUdagawa, O., Kato-Udagawa, A., & Hirano, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168656 · Cited by 2
SIRT1720 promotes survival of corneal epithelial cells via the P53 pathway
Jalil, H. A., Al-Sudani, B. T., & Jasim, G. A. (2022) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2022.906 · Cited by 3
Xu, Z., Yang, M., Ou, C., Mao, L., & Liu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619944 · Cited by 1
Integrating condensates into protein lifespan – From birth to death
Langridge, C. A., & Sontag, E. M. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113271 · Cited by 1
“There is growing recognition that PML bodies may be indicators of DNA damage (114, 115) because PML body concentrations increase as genotoxic stress increases (115, 116).”
Contrôle de la sumoylation par les corps nucléaires PML
Tessier, S. (2018) · theses.fr (ABES) · doi:10.70675/36e48bc6z6df9z4423z85abz5a5b438a22e0
Pascua, A. M. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/121272
Oncologie cellulaire et moléculaire
de Thé, H. (2019) · L’annuaire du Collège de France · doi:10.4000/annuaire-cdf.13943
Le rôle de la SUMOylation dans la différenciation du cortex surrénalien
Dufour, D. (2022) · theses.fr (ABES) · doi:10.70675/3ee859f1zad7az421fz8ed8zccb292efa0d0
Implication de l’axe SETDB1-HUSH-MORC2 dans le contrôle de la latence du virus de l’herpès simplex 1
Roubille, S. (2022) · theses.fr (ABES) · doi:10.70675/f9f13c1azabe6z4ecbza7b8zf2e2c4ad3937
Rôle du système XCT dans l'oncogènese des leucemies augües myeloïdes
Pardieu, B. (2021) · theses.fr (ABES) · doi:10.70675/a354501fz18e2z45e6zbfc6z9f8a2c599d94
Targeting NPM1c in Acute Myeloid Leukemia
Hleihel, R. (2019) · theses.fr (ABES) · doi:10.70675/dadcce67z6277z4db3z8c0cza6518fe9080c
Mécanismes d'assemblage des corps nucléaires PML et ciblage thérapeutique par l'arsenic
Bercier, P. (2023) · theses.fr (ABES) · doi:10.70675/9f4ed6ddz0e15z41bbz8812z0b6604c0b268
Metadata
- Authors
- Niwa-Kawakita, M., Ferhi, O., Soilihi, H., Le Bras, M., Lallemand-Breitenbach, V., & de Thé, H.
- Affiliations
- Université Paris Diderot, Sorbonne Paris Cité, Hôpital St. Louis, Paris, France 1
- Centre National de la Recherche Scientifique (FR)
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-09-20
- Volume
- 214
- Issue
- 11
- Pages
- 3197-3206
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5679165
- OpenAlex
- W2756418816
- Cited by
- 104
- References
- 36
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 14 · 2019: 8 · 2018: 8 · 2017: 2
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Institut National du Cancer
- Association pour la Recherche Contre le Cancer
- European Research Council (268729 – STEMAPL)
- French National Research Agency (ANR-11-PHUC-002, ANR-10-IHUB-0002, ANR-13-JSV2-0005-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- promyelocytic leukemia nuclear bodies, PML, reactive oxygen species detection, oxidative stress, p53 activation, Nrf2, glutathione depletion, acetaminophen hepatotoxicity, longevity, antioxidant function
- MeSH terms
- Promyelocytic Leukemia Protein, Animals, Cells, Cultured, Embryo, Mammalian, Female, Male, Mice, Inbred BALB C, Oxidation-Reduction, Blotting, Western, Tumor Suppressor Protein p53, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Microscopy, Confocal, Intranuclear Inclusion Bodies, NF-E2-Related Factor 2, Mice, 129 Strain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.